Amgen wins protection for anemia drug

Amgen, Inc., the world’s largest biotechnology firm and Tech-Collective member, was featured in The Boston Globe on August 4, 2006 in a story by Bloomberg News regarding its recent win of an appeals court ruling to keep Shire Plc's Dynepo anemia drug out of the US market. [Read More in The Boston Globe]

For more on Amgen, Inc., Click here.

** Remember, that Tech Collective urges members of the technology industry to not only read and post their thoughts on material we provide in our blog, but to also feel free to post issues and topics of their own for others to respond to.**